Filter Validation& integrity test
PDA TR41-2005 病毒过滤

Table of Contents 目录1Introduction 简介9 2General Concepts 一般概念9 2.1Size Exclusion 尺寸排除10 2.2Other Retention Mechanisms 其他滞留方法11 2.3Virus Retention Probability of Reduction Factor (RF) 病毒滞留可能性的减少因素(RF)11 2.4Virus Size/Retention Rating病毒大小/滞留量112.5Protein Size/Sieving/Passage Rating 蛋白质大小/过滤/通过量113 Virus Filter Selection and Characterization 病毒选择和特性12 3.1Filter Construction 过滤器结构12 3.2Filter System Configurations 过滤系统配置12 3.3Particulates and Extractables 微粒和萃取物13 3.4Filter Compatibility 过滤兼容性14 3.5Protein Recovery (Adsorption/Retention/Biocompatibility)蛋白质恢复(吸附/滞留/生物兼容性)15 3.6Thermal Stress Resistance 热应力阻止16 3.7Hydraulic Stress Resistance 水应力阻力16 3.8Toxicity Testing 毒性试验16 3.9Viral/Phage Challenge Testing 病毒/噬菌体挑战试验163.10Cleaning/Sanitization/Sterilization 清理/消毒/灭菌174 Physical and Mechanical Characteristics 物理力学特性17 4.1Filtration Rate and Clogging (Throughput) 过滤速度及堵塞(通过量)17 4.2Fluid/Piping 液体/管道17 4.3Fluid/Filter 液体/过滤器17 4.4Physical and Structural Limitations 物理结构限制174.5Miscellaneous 多样性175 Virus Filter Validation/Evaluation Studies 病毒过滤器/评估研究17 5.1Filter Properties 过滤器属性18 5.2Test Virus 测试病毒18 5.2.1Virus Selection 病毒选择18 5.2.2Virus Stock Preparation and Maintenance 病毒库制备和维护19 5.2.3Virus Spike 病毒峰值20 5.3Scaled-down Models 缩小模型21 5.4Operating Conditions for Validation, Revalidation, and Number of Runs 验证,再验证的运行条件和运行次数21 5.5Raw Materials and Equipment 原材料和设备22 5.5.1Virus Filtration Devices and Configurations 病毒过滤设备和配置22 5.5.2Integrity Testing during Development 研发期间的完整性测试22 5.5.3Membrane Lot Selection 膜批选择22 5.5.4Feedstream 原料流23 5.5.5Filtration Conditions 过滤条件235.6Virus Assays and Assay Validation 病毒分析试验和分析验证5.6.1 Assay Method Validation 试验方法验证23 5.7Establishing Representative Worst-case Process Conditions 确定代表性的最坏工艺条件24 6 Integrity Testing 完整性测试25 6.1Manufacturer's Checklist 生产商检验单26 6.2Virus Retention Integrity Tests 病毒滞留完整性测试27 6.2.1Dextran Retention 葡聚糖滞留27 6.2.2Gold Particle Retention 金颗粒滞留27 6.2.3Gas-Liquid Porosimetry 气-液测量仪29 6.2.4Manual Bubble Point or Leak Testing 人工起泡点或检漏测试29 6.2.5Manual Forward/Diffusive Flow 人工顺流/扩散流29 6.2.6Manual Pressure Hold/Decay 人工压力保持/下降30 6.2.7Automated Integrity Test Instruments for Gas Porosimetry-based Test Methods 基于气体测量仪测试法的自动完整性测试仪器30 6.2.8Liquid and Liquid-liquid Porosimetry 液体和液-液测量仪31 6.3Relationship between Integrity Tests and Virus/Phage Retention 完整性测试和病毒/噬菌体截留之间的关系316.4Failure Analysis/Troubleshooting 故障分析/处理317 Sterilization 灭菌32 7.1Steam Sterilization 蒸汽灭菌32 7.2Autoclave Sterilization 高压蒸汽灭菌32 7.3Sterilize-in-Place (SIP) 在线灭菌32 7.4Irradiation Sterilization 辐射灭菌33 7.5Gas Sterilization 气体灭菌33 APPENDIX A: Virus Retention and Protein Passage Nomenclature Classification 附录A:病毒截留和蛋白质通过的术语分类34 APPENDIX B: Large Virus Filter Experimental Protocol 附录B :大分子病毒过滤器的试验方案35 B.1 Large Virus Filter Experimental Design 大分子病毒过滤器试验设计35 B.1.1 Strategy 策略35 B.1.2 Model Virus 模型病毒35 B.1.3 Model Proteins 模型蛋白质35 B.1.4 Buffer System 缓冲系统35 B.1.5 Scaled-down Model Filters 按比例缩小的模型过滤器35 B.1.6 Operating Parameters 运行参数36 B.1.7 Set Point Values for Relevant Operating Parameters 相关运行参数的设定值36 B.1.8 Nomenclature Acceptance Criteria 命名验收标准36 B.2 Preparation of Bacteriophage Stocks 噬菌群制备37 B.2.1 Introduction 简介37 B.2.2 Equipment 设备37 B.2.3 Procedure 程序38B.2.3.1 Plate Method 培养板的方法38 B.2.3.2 Broth Method 肉汤方法38 B.2.4 Crude Preparation 原料制备38 B.2.5 Pure Concentrate (Coetzee, et al. (25)) 纯浓缩液38 B.3 Procedure For The Estimation of Bacteriophage Numbers 噬菌体数估算程序39 B.3.1 Introduction 简介39 B.3.2 Equipment 设备39 B.3.3 Procedure 程序39 B.3.3.1 Preparation of Bacteriophage Host 噬菌体寄主的制备39 B.3.3.2 Preparation of Dilution Tubes and Soft Agar for Use in Phage Assays 噬菌体分析用的稀释管和软琼脂制备39 B.3.3.3 Phage Assays 噬菌体分析40 APPENDIX C: FILTER VALIDATION RECOMMENDATIONS 附录C:过滤器验证建议411 Introduction 简介Scope: This PDA Technical Report addresses virus removal filters that retain viruses by a size exclusion mechanism. It explains how they work, their selection, char-acterization, testing, and validation.This document should be considered as a guide; it is not intended to establish any mandatory or implied standard. 范围:此PDA技术报告陈述了病毒去除过滤器,该过滤器通过尺寸排除装置拦截病毒。
PDA TR41-2005 病毒过滤

Table of Contents 目录1Introduction 简介9 2General Concepts 一般概念9 2.1Size Exclusion 尺寸排除10 2.2Other Retention Mechanisms 其他滞留方法11 2.3Virus Retention Probability of Reduction Factor (RF) 病毒滞留可能性的减少因素(RF)11 2.4Virus Size/Retention Rating病毒大小/滞留量112.5Protein Size/Sieving/Passage Rating 蛋白质大小/过滤/通过量113 Virus Filter Selection and Characterization 病毒选择和特性12 3.1Filter Construction 过滤器结构12 3.2Filter System Configurations 过滤系统配置12 3.3Particulates and Extractables 微粒和萃取物13 3.4Filter Compatibility 过滤兼容性14 3.5Protein Recovery (Adsorption/Retention/Biocompatibility)蛋白质恢复(吸附/滞留/生物兼容性)15 3.6Thermal Stress Resistance 热应力阻止16 3.7Hydraulic Stress Resistance 水应力阻力16 3.8Toxicity Testing 毒性试验16 3.9Viral/Phage Challenge Testing 病毒/噬菌体挑战试验163.10Cleaning/Sanitization/Sterilization 清理/消毒/灭菌174 Physical and Mechanical Characteristics 物理力学特性17 4.1Filtration Rate and Clogging (Throughput) 过滤速度及堵塞(通过量)17 4.2Fluid/Piping 液体/管道17 4.3Fluid/Filter 液体/过滤器17 4.4Physical and Structural Limitations 物理结构限制174.5Miscellaneous 多样性175 Virus Filter Validation/Evaluation Studies 病毒过滤器/评估研究17 5.1Filter Properties 过滤器属性18 5.2Test Virus 测试病毒18 5.2.1Virus Selection 病毒选择18 5.2.2Virus Stock Preparation and Maintenance 病毒库制备和维护19 5.2.3Virus Spike 病毒峰值20 5.3Scaled-down Models 缩小模型21 5.4Operating Conditions for Validation, Revalidation, and Number of Runs 验证,再验证的运行条件和运行次数21 5.5Raw Materials and Equipment 原材料和设备22 5.5.1Virus Filtration Devices and Configurations 病毒过滤设备和配置22 5.5.2Integrity Testing during Development 研发期间的完整性测试22 5.5.3Membrane Lot Selection 膜批选择22 5.5.4Feedstream 原料流23 5.5.5Filtration Conditions 过滤条件235.6Virus Assays and Assay Validation 病毒分析试验和分析验证5.6.1 Assay Method Validation 试验方法验证23 5.7Establishing Representative Worst-case Process Conditions 确定代表性的最坏工艺条件24 6 Integrity Testing 完整性测试25 6.1Manufacturer's Checklist 生产商检验单26 6.2Virus Retention Integrity Tests 病毒滞留完整性测试27 6.2.1Dextran Retention 葡聚糖滞留27 6.2.2Gold Particle Retention 金颗粒滞留27 6.2.3Gas-Liquid Porosimetry 气-液测量仪29 6.2.4Manual Bubble Point or Leak Testing 人工起泡点或检漏测试29 6.2.5Manual Forward/Diffusive Flow 人工顺流/扩散流29 6.2.6Manual Pressure Hold/Decay 人工压力保持/下降30 6.2.7Automated Integrity Test Instruments for Gas Porosimetry-based Test Methods 基于气体测量仪测试法的自动完整性测试仪器30 6.2.8Liquid and Liquid-liquid Porosimetry 液体和液-液测量仪31 6.3Relationship between Integrity Tests and Virus/Phage Retention 完整性测试和病毒/噬菌体截留之间的关系316.4Failure Analysis/Troubleshooting 故障分析/处理317 Sterilization 灭菌32 7.1Steam Sterilization 蒸汽灭菌32 7.2Autoclave Sterilization 高压蒸汽灭菌32 7.3Sterilize-in-Place (SIP) 在线灭菌32 7.4Irradiation Sterilization 辐射灭菌33 7.5Gas Sterilization 气体灭菌33 APPENDIX A: Virus Retention and Protein Passage Nomenclature Classification 附录A:病毒截留和蛋白质通过的术语分类34 APPENDIX B: Large Virus Filter Experimental Protocol 附录B :大分子病毒过滤器的试验方案35 B.1 Large Virus Filter Experimental Design 大分子病毒过滤器试验设计35 B.1.1 Strategy 策略35 B.1.2 Model Virus 模型病毒35 B.1.3 Model Proteins 模型蛋白质35 B.1.4 Buffer System 缓冲系统35 B.1.5 Scaled-down Model Filters 按比例缩小的模型过滤器35 B.1.6 Operating Parameters 运行参数36 B.1.7 Set Point Values for Relevant Operating Parameters 相关运行参数的设定值36 B.1.8 Nomenclature Acceptance Criteria 命名验收标准36 B.2 Preparation of Bacteriophage Stocks 噬菌群制备37 B.2.1 Introduction 简介37 B.2.2 Equipment 设备37 B.2.3 Procedure 程序38B.2.3.1 Plate Method 培养板的方法38 B.2.3.2 Broth Method 肉汤方法38 B.2.4 Crude Preparation 原料制备38 B.2.5 Pure Concentrate (Coetzee, et al. (25)) 纯浓缩液38 B.3 Procedure For The Estimation of Bacteriophage Numbers 噬菌体数估算程序39 B.3.1 Introduction 简介39 B.3.2 Equipment 设备39 B.3.3 Procedure 程序39 B.3.3.1 Preparation of Bacteriophage Host 噬菌体寄主的制备39 B.3.3.2 Preparation of Dilution Tubes and Soft Agar for Use in Phage Assays 噬菌体分析用的稀释管和软琼脂制备39 B.3.3.3 Phage Assays 噬菌体分析40 APPENDIX C: FILTER VALIDATION RECOMMENDATIONS 附录C:过滤器验证建议411 Introduction 简介Scope: This PDA Technical Report addresses virus removal filters that retain viruses by a size exclusion mechanism. It explains how they work, their selection, char-acterization, testing, and validation.This document should be considered as a guide; it is not intended to establish any mandatory or implied standard. 范围:此PDA技术报告陈述了病毒去除过滤器,该过滤器通过尺寸排除装置拦截病毒。
如何使用Excel进行数据验证和筛选

如何使用Excel进行数据验证和筛选Excel是一款强大的办公软件,它不仅可以进行数据录入和计算,还可以进行数据验证和筛选,以确保数据的准确性和完整性。
本文将介绍如何使用Excel进行数据验证和筛选的方法和技巧。
1. 数据验证(Data Validation)数据验证用于限制用户在单元格中输入的数据类型和范围,以减少错误和提高数据的准确性。
下面是使用Excel进行数据验证的步骤:(1)选择需要添加数据验证的单元格或单元格区域;(2)点击“数据”选项卡,在“数据工具”组中选择“数据验证”;(3)在弹出的“数据验证”对话框中,选择所需的验证条件和设置选项,如允许的数据类型、数据范围等;(4)点击“确定”完成数据验证的设置。
例如,如果要限制某个单元格只能输入数字,可以选择“整数”或“小数”等数据类型,并设置允许的数据范围。
2. 条件格式化(Conditional Formatting)条件格式化用于根据特定的条件对数据进行格式化,并可以快速识别和分析数据。
下面是使用Excel进行条件格式化的步骤:(1)选择需要进行条件格式化的单元格或单元格区域;(2)点击“开始”选项卡,在“样式”组中选择“条件格式化”;(3)在下拉菜单中选择所需的条件格式化规则,如高亮单元格规则、数据条规则等;(4)在弹出的对话框中,设置条件格式化的规则和格式选项,如设置数值范围、文本匹配等;(5)点击“确定”完成条件格式化的设置。
例如,可以使用条件格式化将数值大于某个阈值的单元格标记为红色,以便在数据中快速识别出异常值。
3. 数据筛选(Filter)数据筛选用于按照特定的条件在数据表中筛选出符合要求的数据,并隐藏不符合条件的数据。
下面是使用Excel进行数据筛选的步骤:(1)选择数据表格的区域;(2)点击“开始”选项卡,在“编辑”组中选择“筛选”;(3)点击筛选工具栏上的小箭头,选择所需的筛选条件;(4)根据条件设置筛选,可以选择多个条件进行组合筛选;(5)点击“确定”完成筛选。
validation注解用法

validation注解用法
在Java中,Validation注解通常用于验证对象的属性是否符
合特定的规则或约束。
这些注解可以帮助开发人员在编写代码时轻
松地添加验证逻辑,从而确保数据的完整性和一致性。
以下是一些
常见的Validation注解用法:
1. @NotNull,用于标记字段不能为空,适用于任何类型的字段。
2. @Size,用于验证字符串、集合或数组的大小是否在指定范
围内。
3. @Min和@Max,分别用于验证数字类型的最小值和最大值。
4. @Email,用于验证字段是否符合电子邮件地址的格式。
5. @Pattern,用于基于正则表达式的验证,可以自定义验证条件。
6. @NotBlank,用于验证字符串类型的字段不能为空,并且去
除空格后长度必须大于0。
7. @AssertTrue和@AssertFalse,分别用于验证字段值是否为true或false。
这些注解可以直接应用于Java Bean的属性上,或者可以与Hibernate Validator等验证框架一起使用。
在实际应用中,开发
人员可以根据业务需求自由组合这些注解,以实现复杂的验证逻辑。
另外,也可以自定义Validation注解,以满足特定业务场景下的验
证需求。
总之,Validation注解在Java中是非常有用的工具,可以帮
助开发人员轻松地实现数据验证,提高代码的健壮性和可靠性。
希
望以上回答能够满足你的需求,如果有其他问题,请随时提出。
filter函数的用法多条件

filter函数的用法详解:多条件中的特定函数1. 定义filter函数是Python内置的一个高阶函数,用于对可迭代对象(例如列表、元组、字典、集合等)中的元素进行过滤,并返回满足特定条件的元素。
filter函数的定义如下:filter(function, iterable)其中,function是一个函数,用于对可迭代对象的每个元素进行判断,返回True或False;iterable是一个可迭代对象,可以是列表、元组、字典、集合等。
2. 用途filter函数主要用于对可迭代对象进行筛选,过滤出满足特定条件的元素,从而得到一个新的可迭代对象。
它可以简化代码,提高代码的可读性和可维护性。
filter函数常用于以下场景:•过滤出满足特定条件的元素,例如筛选出大于某个阈值的数字、筛选出包含特定字符的字符串等。
•过滤出满足多个条件的元素,例如同时满足某个范围和某个条件的数字。
•过滤出满足函数返回值为True的元素,例如根据某个函数的返回值来筛选元素。
3. 工作方式filter函数的工作方式如下:•对于可迭代对象中的每个元素,依次调用function函数,并将元素作为参数传入。
•如果function函数的返回值为True,则将该元素保留下来;如果返回值为False,则将该元素过滤掉。
•最后,将所有保留下来的元素组成一个新的可迭代对象,并返回。
示例代码如下:# 过滤出大于5的数字numbers = [1, 2, 3, 4, 5, 6, 7, 8, 9]result = filter(lambda x: x > 5, numbers)print(list(result)) # 输出 [6, 7, 8, 9]在上述示例中,lambda函数lambda x: x > 5用于判断数字是否大于5,filter函数根据这个lambda函数的返回值来过滤出大于5的数字。
4. 多条件中的特定函数在实际应用中,我们经常需要对可迭代对象进行多条件的筛选。
过滤芯完整性测试资料方案

Business Practice 商业惯例 Government Guidelines & Regulations法规要求 Part of corporate standard operating procedure公司标准操作规程 Auditing requirement审计需要
Regulations about integrity test 法规中对完整性测试的规定
该包括在最差条件下进行的微生物挑战试验。
Regulations about integrity test
法规中对完整性测试的规定
• Revision of annex 1 to EC Guide to GMP for sterile medicinal products (1997)
• 欧盟对于无菌药品GMP指南的附件一(1997版)
破坏性和非破坏性测试两者必须 有关联
Regulatory requirement 法规需要
FDA Aseptic Guidelines FDA无菌指南
Validation justification for the use of a test 测试应用的验证理由
Integrity Testing
Correlations 完整性测试关联
dubbo学习笔记(二)dubbo中的filter
dubbo学习笔记(⼆)dubbo中的filterdubbo框架提供了filter机制的扩展点(本⽂基于dubbo2.6.0版本)。
扩展接⼝在dubbo-rpc模块下的dubbo-rpc-api模块下定义了Filter接⼝:org.apache.dubbo.rpc.Filterdubbo⾃带的filterdubbo框架⾃带了22个Filter。
在dubbo-rpc-api模块提供了15个filter:AccessLogFilterActiveLimitFilterClassLoaderFilterCompatibleFilterConsumerContextFilterContextFilterDeprecatedFilterEchoFilterExceptionFilterExecuteLimitFilterGenericFilterGenericImplFilterTimeoutFilterTokenFilterTpsLimitFilterdubbo-rpc-default模块提供了2个filter:FutureFilterTraceFilterdubbo-filter模块有2个⼦模块,提供了2个filter:dubbo-filter-cache提供了1个Filter:CacheFilterdubbo-filter-validation提供了1个Filter:ValidationFilterdubbo-test-examples提供了1个filter:LogFilterdubbo-spring-config提供了1个filter:MockFilterdubbo-monitor-api提供了1个filter:MonitorFilterFilter加载dubbo应⽤启动时,通过ProtocolFilterWrapper#buildInvokerChain构建了filter的调⽤链。
启⽤demo应⽤,在buildInvokerChain⽅法的List<Filter> filters = ExtensionLoader.getExtensionLoader(Filter.class).getActivateExtension(invoker.getUrl(), key, group);下⼀⾏打个断点,在调试窗⼝看观察List<Filter> filters的值,provider端:consumer端:Filter加载顺序系统⾃带的filter,上⾯的图可以可以看到,provider端:EchoFilter->ClassLoaderFilter->GenericFilter->ContextFilter->TraceFilter->TimeoutFilter->MonitorFilter->ExceptionFilter consumer端:ConsumerContextFilter->FutureFilter->MonitorFilter@Active注解定义了Filter的位置和顺序,其中group属性定义了该Filter⽤于Provider或Consumer端,order属性定义了Filter的绝对顺序(数值⼩的排在前⾯)。
validation用法
validation用法Validation是指在数据输入、处理或输出过程中,对数据的合法性进行检查和验证的过程。
在软件开发中,数据的合法性非常重要,因此需要使用Validation来确保数据的正确性和完整性。
本文将介绍Validation的基本概念、原则、方法和实现。
一、概念1.1 Validation定义Validation是指对数据进行检查和验证的过程,确保数据符合规定的条件、要求和标准。
1.2 Validation目的Validation的目的是确保输入、处理或输出的数据符合系统设计要求,并且能够满足用户需求。
1.3 Validation原则Validation应该遵循以下原则:(1)有效性:验证结果应该能够正确地反映出数据是否符合规定条件。
(2)可靠性:验证结果应该具有可重复性,即同样的输入应该得到同样的输出。
(3)完整性:所有必要信息都应该被验证,并且不会漏掉任何一个必要信息。
(4)及时性:验证应该在最早可能时间进行,以便及时发现错误并纠正。
二、方法2.1 数据类型验证数据类型验证是指对输入数据类型进行检查和确认。
例如,在一个数字型字段中输入了非数字字符,则会提示错误信息并拒绝保存。
这种方法可以有效地防止非法字符输入,从而提高系统安全性。
2.2 数据格式验证数据格式验证是指对输入数据格式进行检查和确认。
例如,在一个邮件地址字段中输入了错误的邮件地址,系统会提示错误信息并拒绝保存。
这种方法可以有效地防止错误格式输入,从而提高系统可靠性。
2.3 数据范围验证数据范围验证是指对输入数据范围进行检查和确认。
例如,在一个年龄字段中输入了负数或超过规定范围的数字,则会提示错误信息并拒绝保存。
这种方法可以有效地防止非法数据输入,从而提高系统完整性。
2.4 数据逻辑验证数据逻辑验证是指对输入数据逻辑关系进行检查和确认。
例如,在一个订单表中,订单数量不能大于库存数量,则会提示错误信息并拒绝保存。
这种方法可以有效地防止逻辑错误输入,从而提高系统精确度。
validation条件校验非空
validation条件校验非空一、什么是validation条件校验Validation(条件校验)是一种检查数据有效性的方法,主要用于确保用户输入的数据满足预先设定的规则。
在软件开发过程中,validation可以有效地减少错误数据进入系统的可能性,提高系统的稳定性和工作效率。
二、validation校验的重要性1.提高数据质量:validation校验可以帮助我们过滤掉不合法、不完整或不符合预期的数据,从而提高数据质量。
2.减轻系统负担:通过validation校验,可以在前端过滤掉错误数据,避免错误数据传递到后端,降低系统处理的复杂性。
3.提升用户体验:validation校验可以实时地提示用户修改错误数据,降低用户在使用过程中的挫败感。
4.防止安全漏洞:validation校验可以有效防止恶意攻击,如SQL注入、跨站脚本等。
三、常见validation校验方法1.非空校验:检查数据是否为空,如字符串、列表、字典等。
2.格式校验:检查数据格式是否符合预期,如邮箱地址、手机号码、身份证号码等。
3.范围校验:检查数据是否在预设的范围内,如年龄、价格、分数等。
4.唯一性校验:检查数据是否已经存在,如用户名、密码等。
5.逻辑校验:检查数据之间的逻辑关系,如密码和确认密码、年龄和性别四、如何在Python中进行validation校验1.使用内置库:Python内置了`validate`库,可以用于简单的基本校验。
如:```pythonimport validatedef validate_email(email):result = validate.is_email(email)return resultresult=validate_email("*******************")print(result) # 输出:True```2.自行编写校验函数:根据实际需求,编写针对性的校验函数。
德国赛多利斯过滤工艺验证培训
Sunday, September 12, 2010
Seite 11
ISO 13408-2 Aseptic processing of healthcare products (2003) Part 2: Filtration
„ „ „ „
过滤器的使用者必须评估过滤器的性能 过滤器评估必须考虑到具体料液和具体工艺 过滤器的性能必须不能受料液的影响 药品质量不能反受过滤器的影响
- 1、下载文档前请自行甄别文档内容的完整性,平台不提供额外的编辑、内容补充、找答案等附加服务。
- 2、"仅部分预览"的文档,不可在线预览部分如存在完整性等问题,可反馈申请退款(可完整预览的文档不适用该条件!)。
- 3、如文档侵犯您的权益,请联系客服反馈,我们会尽快为您处理(人工客服工作时间:9:00-18:30)。
Filter ValidationBiopharmaceutical processes are validated processes to assure a reproducible product quality within set specifications. Equally important is the validation of the filters used within the process, especially the sterilizing grade filters, which often enough are used before filling or final processing of the drug product. In its Guideline on General Principles of Process Validation (1985) and Guideline on Sterile Drug Products Produced by Aseptic Processing (2004), the Food and Drug Administration (FDA) makes plain that the validation of sterile processes is required by the manufacturers of sterile products. Similar demands can be found in ISO 13408-2 (2003), EudraLexVol 4 Annex 1 (2008) and PDA Technical Report #26 (2008), the latter being the most comprehensive in the description of filter validation needs.Sterilizing grade filters are determined by the bacteria challenge tests. This test is performed under strict parameters and a defined solution (ASTM F 838-05). Since the ASTM challenge test assesses the filter only under standard conditions, regulatory authorities require also evidence, that the sterilizing grade filter will create a sterile filtrate, no matter of the process, fluid or bioburden found. This means that bacteria challenge tests have to be performed with the actual drug product, bioburden, if different or known to be smaller than Brevundimonasdiminuta and the process parameters. The reason for the requirement of a product bacteria challenge test is threefold. First of all the influence of the product and process parameters to the microorganism has to be tested. There may be cases of either shrinkage of organisms due to a higher osmolarity of the product or prolonged processing times. Secondly the filters compatibility with the product and the parameters has to be tested. The filter should not show any sign of degradation due to the product filtered. Additionally rest assurance is required that the filter used will withstand the process parameters, e.g. pressure pulses, if happening, should not influence the filters performance. Thirdly, there are two separation mechanisms involved in liquid filtration; sieve retention and retention by adsorptive sequestration. In sieve retention the smallest particle or organism size is retained by the biggest pore within the membrane structure. The contaminant will be retained, no matter of the process parameters. This is the ideal and best retention assurance. Retention by adsorptive sequestration depends on the filtration conditions. Contaminants smaller than the actual pore size penetrate such and may be captured by adsorptive attachment to the pore wall or by bridging effects. This effect is enhanced using highly adsorptive filter materials, for example glass fiber or diatomaceous earth as a prefilter or Polyamide as a membrane. Nevertheless certain liquid properties, e.g. pH or surfactant content, can minimize the adsorptive effect, which could mean penetration of organisms. Whether the fluid has such properties and will lower the effect of adsorptive sequestration and may eventually cause penetration has to be evaluated in specific product bacteria challenge tests.Before performing a product bacteria challenge test, it has to be assured that the liquid product does not have any detrimental, bactericidal or bacteriostatic, effects on the challenge organisms. This is done utilizing viability tests. The organism is inoculated into the product to be filtered at a certain bioburden level. At specified times the log value of this bioburden is tested. If the bioburden is reduced due to the fluid properties different bacteria challenge test mode become applicable. If the reduction is a slow process the challenge test can be performed with a higher bioburden level, bearing in mind that the challenge level has to reach 107 per square centimeter filtration area at the end of the processing time. If the mortality rate is too high the toxic substance is either removed orproduct properties are changed, always having the viability results at hand to explain such changes. This challenge fluid is called a placebo. Another methodology would circulate the fluid product through the filter at the specific process parameters as long as the actual processing time would be. Afterwards the filter is flushed extensively with water and the challenge test, as described in ASTM F838-05, performed. Nevertheless such challenge test procedure would be more or less a filter compatibility test.Besides the product bacteria challenge test, tests of extractable/leachable substances and/or particulate releases have to be performed. Extractable measurements and the resulting data are available from filter manufacturers for the individual filters. Nevertheless depending on the process conditions and the solvents used, product and process specific extractable tests have to be performed. These tests are commonly done only with the solvent used with the drug product, but not with the drug ingredients themselves, because the drug product usually covers any extractables profile during measurement. Such tests are conducted by the validation services of the filter manufacturers using sophisticated separation and detection methodologies, as GC-MS, FTIR and RP-HPLC. These methodologies are required due to the fact that the individual components possibly released from the filter have to be identified and quantified. Elaborated studies, performed by filter manufacturers showed that there is neither a release of high quantities of extractables (the range is ppb to max. ppm per 10" element) nor have been toxic substances been found.Particulates are critical in sterile filtration, specifically of injectables. The USP (United States Pharmacopeia) and BP (British Pharmacopeia) quote specific limits of particulate level contaminations for defined particle sizes. These limits have to be met. Filters are routinely tested, evaluating the filtrate with laser particle counters. Such tests are also performed with the actual product under process conditions to proof that the product, but especially process conditions do not result in an increased level of particulates within the filtrate.Additionally with certain products loss of yield or product ingredients due to adsorption shall be determined. For example preservatives, like benzalkoniumchloride or chlorhexadine, can be adsorbed by specific filter membrane polymers. Such membranes need to be saturated with the preservative to avoid preservative loss within the actual product. This preservative loss, e.g. in contact lense solutions or nasal sprays, can be detrimental due to long-term use of such solutions. Similarly problematic would be the adsorption of required proteins within a biological solution. To optimize the yield of such proteins within an application, small scale adsorption trials are recommended to find the optimal membrane material and filter construction.Other routine validation or qualification tests would be flow rate and throughput determination, thermal and mechanical stability for example during in-line steam sterilization or any pulsations during the filtration process.Filter Integrity TestingSterilizing grade filters require to be tested to assure the filters are integral and fulfill its purpose. Such filter tests are called integrity test and are performed before and after the filtration process. Sterilizing grade filtration would not be admitted to a process, if the filter would not be integrity tested in the course of the process. This fact is also established inseveral guidelines, recommending the use of integrity testing, pre- and post-filtration. This is not only valid for liquid, but also air filters.Examples of such guidelines are:FDA "Guideline on Sterile Drug Products Produced by Aseptic Processing" (2004), "Normally, integrity testing of the filter is performed after the filter unit is assembled and prior to use. More importantly however, such testing should be conducted after the filter is used in order to detect any filter leaks or perforations that may have occurred during filtration."EudraLex, Volume 4, Annex I (2008)"113. The integrity of the sterilized filter should be verified before use and should be confirmed immediately after use by an appropriate method such as a bubble point, diffusive flow or pressure hold test. The time taken to filter a known volume of bulk solution and the pressure difference to be used across the filter should be determined during validation and any significant differences from this during routine manufacturing should be noted and investigated. Results of these checks should be included in the batch record. The integrity of critical gas and air vent filters should be confirmed after use. The integrityof other filters should be confirmed at appropriate intervals."ISO 13408-2 "First edition, 2003-03-15, Aseptic processing of health care products", Part 2: Filtration (2003)"9.5 The validated physical integrity test of a sterilizing filter shall be conducted after each use without disturbing the filter in its housing. Physical integrity testing of a sterilizing filter in situ should be conducted before use after sterilization where the design of the filtration system permits.Care should be taken not to compromise the sterility of the filter."USP (United States Pharmacopoeia) 23, (1995)Guide to Good Pharmaceutical Manufacturing Practice (Orange Guide, U.K., 1983,)PDA (Parenteral Drug Association), Technical Report No. 26, "Sterilizing Filtration of Liquids" (March 1998, revised 2008)Integrity tests, as the Diffusive Flow, Pressure Hold, Bubble Point or Water Intrusion Test, are non-destructive tests, which are correlated to the destructive bacteria challenge test with 107 per square centimeter Brevundimonasdiminuta . Derived from these challenge tests specific integrity test limits are established, which are described and documented within the filter manufacturer's literature. The limits are water based, i.e. the integrity test correlations are performed using water as a wetting medium. If a different wetting fluid, respectively filter or membrane configuration is used the integrity test limits mayvary. Integrity test measurements depend on the surface area of the filter, the polymer of the membrane, the wetting fluid, the pore size of the membrane and the gas used to perform the test. Wetting fluids may have different surface tensions, which can depress or elevate the Bubble Point pressure. The use of different test gases may elevate thediffusive gas flow. Therefore appropriate filter validation has to determine the appropriate integrity test limits for the individual process, if a process fluid is utlized.Bubble Point TestMicro-porous membranes will fill their pores with wetting fluids by imbibing that fluid in accordance with the laws of capillary rise. The retained fluid can be forced from the filter pores by air pressure applied from the upstream side. The pressure is increased in gradually in increments. At a certain pressure level, liquid will be forced first from the set of largest pores, in keeping with the inverse relationship of the applied air pressure P and the diameter of the pore, d, described in the bubble point equation:P = 4 cosdwhere ; is the surface tension of the fluid and ; is the wetting angle; P is the upstream pressure at which the largest pore will be freed of liquid, d is the diameter of the largest pore.When the wetting fluid is expelled from the largest pore, a bulk gas flow will be detected on the downstream side of the filter system. The Bubble Point measurement determines the pore size of the filter membrane, i.e. the larger the pore the lower the Bubble Point pressure. Therefore filter manufacturers specify the Bubble Point limits as the minimum allowable Bubble Point. During an integrity test the Bubble Point test has to exceed the set minimum Bubble Point.Diffusion TestA completely wetted filter membrane provides a liquid layer across which, when a differential pressure is applied, the diffusive airflow occurs in accordance with Fick's law of diffusion. The upstream pressure applied is called test pressure and commonly specified at ~80 % of the Bubble Point pressure. In an experimental elucidation of the factors involved in the process, Reti simplified the integrated form of Fick's law to readN = DH (p1 - p2)Lwhere N is the permeation rate (moles of gas per unit time), D is the diffusivity of the gas in the liquid, H is the solubility coefficient of the gas, L is the thickness of liquid in the membrane (equal to the membrane thickness if the membrane pores are completely filled with liquid), P (p1-p2) is the differential pressure, and is the void volume of the membrane, its membrane porosity, commonly around 80-85 %.The size of pores does only enter indirectly into the equation; in their combination they comprise L, the thickness of the liquid layer, the membrane being some 80-85 % porous. The critical measurement of a flaw is the thickness of the liquid layer. Therefore a flaw or an oversized pore would be measured by the thinning of the liquid layer due to the elevated test pressure on the upstream side. The pore or defect may not be large enough that the Bubble Point comes into effect, but the test pressure thins the liquid layer enough to result into an increased gas flow. Therefore filter manufacturer specify the Diffusive Flow integrity test limits as maximum allowable diffusion value. The larger the flaw or a combination of flaws the higher the diffusive flow.Pressure Hold TestThe pressure hold test, also known as pressure decay or pressure drop test, is a variant of the diffusive airflow test. The test set-up is arranged as in the diffusion test except that when the stipulated applied pressure is reached, the pressure source is valved off (Figure 9.). The decay of pressure within the holder is then observed as a function of time, by using a precision pressure gauge or pressure transducer.The decrease in pressure can come from two sources, a.) the diffusive loss across the wetted filter. Since the upstream side pressure in the holder is constant, it decreases progressively all the while diffusion takes place through the wetted membrane or b.) the source of pressure decay could be a leak of the filter system setup.An important influence on the measurement of the Pressure Hold test is the upstream air volume within the filter system. This volume has to be determined first to specify the maximum allowable pressure drop value. The larger the upstream volume, the lower the pressure drop or the smaller the upstream volume, the larger the pressure drop. This means also an increase in sensitivity of the test, but also an increase of temperature influences, if changes occur. Filter manufacturersspecifymaximumallowable pressure drop values.Water Intrusion TestThe Water Intrusion test, also known as Water Flow Integrity test, is used for hydrophobic vent and air membrane filters only. The upstream side of the hydrophobic filter cartridge housing is flooded with water. The water will not flow through the hydrophobic membrane. Air or nitrogen gas pressure is then applied to the upstream side of the filter housing above the water level to a defined test pressure. This is done by way of an automatic integrity tester. A period of pressure stabilization takes place over, by the filter manufacturer recommended, timeframe, during which the cartridge pleats adjust their positions under imposed pressures. After the pressure drop thus occasioned stabilizes, the test time starts and any further pressure drop in the upstream pressurized gas volume, as measured by the automatic tester, signifies a beginning of water intrusion into the largest (hydrophobic) pores, water being incompressible. The automated integrity tester is sensitive enough to detect the pressure drop. This measured pressure drop is converted into a measured intrusion value, which is compared to a set intrusion limit, which has been correlated to the bacteria challenge test. As with the Diffusive Flow test, filter manufacturers specify a maximum allowable water intrusion value. Above this value a hydrophobic membrane filter is classified as non-integral.Product Wet Integrity TestingIn cases of using the actual product as a wetting agent to perform integrity tests require the evaluation of product integrity test limits. The product can have an influence on the measured integrity test values due to surface tension or solubility. A lower surface tension for example would shift the Bubble Point value to a lower pressure and could result in a false negative test. The solubility of gas into the product could be reduced, which could result in false positive tests. Therefore a correlation of the product as wetting agent to the, by the filter manufacturer established, water wet values has to be done. This correlation is carried out by using a minimum of three filters of three filter lots. Depending on the product and its variability, one or three product lots are used to perform the correlation. The accuracy of such correlation is enhanced by automatic integrity test machines. These test machines measure with highest accuracy and sensitivity and do not rely on a humanjudgement as with a manual test. Multipoint diffusion testing offers the ability to test the filters performance, but especially the plot the entire diffusive flow graph through the Bubble Point. The individual graphs for a water wet integrity test can now be compared to the product wet test and a possible shift evaluated. Furthermore the multipoint diffusion test enables an improved statistical base to determine the product wet versus water wet limits.Automated Integrity TestingMost integrity tests are nowadays performed with qualified automated integrity test systems, which allow an easy and accurate test of choice by the end-user. The end-user programs the test parameter into the unit and when required chose the test needed for the specific filter, connect the unit to the pre-wetted filter system and let the machine run the test. The integrity test machine testing the filter system is by far more accurate than a manual test. Besides these machines provide a hardcopy print-out and/or have the ability to store the results in a data storage system.GuidancesPDA Technical Report #26, 2008:Probably the most thorough and detailed document for liquid sterilizing grade filtration. Validation requirements are described in detail and the report gives practical description of what requires to be done and why. The report is not meant as a guidance but as an educational tool. However, since the report is as thorough, it is used by everybody including regulators.Other PDA Technical Reports are:TR #15 Validation of Tangential Flow Filtration in Biopharmaceutical ApplicationsTR #40 Sterilizing Filtration of GasesTR #41 Virus FiltrationTR #45 Filtration of Liquids Using Cellulose-Based Depth FiltersFDA Aseptic Processing Guidance, 2004:The aseptic guidance succeeding the 1987 guidance. Multiple topics are described and a must read for aseptic processing guidance. The guidance also describes filter process validation activities.FDA Changes to NDA/ANDA, 2004:A good guidance to check since it creates a view of post approval change perspectives of what are moderate or major changes considered.EC GMP Guidance, Annex 1, 2008:Again a must read document. It has a distinct prejudice against filtration, which is unfortunate since aseptic processing will increase with increasing biotech drug applications. It would be good to realize that sterilezation grade filtration is more robust than described as this technology has evolved over the last years. Paragraph 113 promotes pre-filtration integrity testing of a sterilized filter, which from a risk management standpoint includes a higher risk level than not testing the filter.EMEA CPMP/QWP/486/95, 1996:The document includes the controversial 10cfu/100ml pre-filtration bioburden limit. It describes that when the bioburden of 10cfu/100ml is exceeded, one has to use another filter to reduce the bioburden below the set limit. However, sterilizing grade filters are validated to remove 10 to 7 Brevundimonasdiminuta per square centimeter, by far higher than the limit specified by the guidance document.ISO 13408 Part 2, 2003:The document describes filtration processes and validation needs of sterilizing grade filters.PQRI PAC, 2007:Post approval changes are reviewed under risk managementWarning Letters:Learn from the warning letter database within the FDA web site. These warning letters, as unfortunate as these are, create always a good learning tool and creates a glimpse of what is of importance and where can it go wrong.。